71P A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NCT03991819)
Authors:
- C. TheriauCTC. Theriau
- J. FengJFJ. Feng
- L. EngLEL. Eng
- F.A. ShepherdFSF.A. Shepherd
- M. De CarolisMCM. De Carolis
- V. GlennsVGV. Glenns
- S. KulkarniSKS. Kulkarni
- R. VandermeerRVR. Vandermeer
- U. Zurawska-FortinUZU. Zurawska-Fortin
- D. HaoDHD. Hao
- L. LeLLL. Le
- I. WozniczkaIWI. Wozniczka
Open Access
Abstract
No abstract availableFunding Information
- Princess Margaret Cancer Foundation